Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
December 11, 2024
Membership lapse means losing access to your member-exclusive resources. Renew your membership for 2025 and receive priority consideration for awards, grants, and professional development programs.
December 17, 2024
Applications are now open for the Early Investigator Awards, honoring outstanding achievements by early career endocrine researchers. Apply now to showcase your work and its impact within the global endocrine community. Applications close January 15, 2025.
December 06, 2024
There is no better place to share your research than ENDO. Taking place July 12-15 in San Francisco, CA, ENDO 2025 will feature thousands of scientific presentations. Submitting an abstract for presentation at ENDO earns media coverage for your work, connects you with scientific investigators with similar interests, and helps drive future research.
December 06, 2024
Make this holiday season memorable with thoughtful gifts that celebrate the endocrinologists in your life. Shop today to save 10% through December 31.
December 20, 2024
The Society celebrates a year full of advocacy accomplishments.
Need more info?
Learn more about the advantages of membership
December 10, 2024
Early life exposure to a class of endocrine-disrupting chemicals (EDCs) called polychlorinated biphenyls (PCBs) may lead to behavioral problems in rats, according to a new animal study published in the Journal of the Endocrine Society.
November 12, 2024
Vitamin D supplements may lower blood pressure in older people with obesity and taking more than the Institutes of Medicine’s (IOM) recommended daily dose does not provide additional health benefits, according to new research published in the Journal of the Endocrine Society.
November 06, 2024
Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications.
December 17, 2024
The authors present a 24-year-old woman with a 1-month history of polydipsia, polyuria, and 25-lb (11.3-kg) weight loss over 6 months, as well as an elevated 24-hour urine volume (8.4 L).
December 17, 2024
Our initial objective was to describe the pattern of postnatal growth hormone (GH) surge in mice and rats and compare it with the secretion of other pituitary hormones, then we investigated possible mechanisms that control the neonatal GH surge in mice.
December 17, 2024
This review focuses on the pharmacological landscape, encompassing single and dual agonist therapies targeting glucagon receptors, glucagon-like peptide-1 receptors, glucose-dependent insulinotropic polypeptide receptors, amylin, triiodothyronine, fibroblast growth factor 21, and peptide tyrosine tyrosine.
